グローバル製薬産業サーベイ（2013-2014）：市場動向、マーケティング戦略...市場調査レポートについてご紹介

1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Global pharmaceutical industry: profile of buyer respondents
1.4.2 Global pharmaceutical industry: profile of supplier respondents
2 Executive Summary
3 Global Pharmaceutical Industry Dynamics
3.1 Revenue Growth Projections in the Global Pharmaceutical Industry
3.1.1 Revenue growth projections by company type
3.1.2 Revenue growth projections by region
3.1.3 Revenue growth projections by company turnover
3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
3.2 Future Developments in Business Structure in the Global Pharmaceutical Industry
3.2.1 Future developments in business structure by buyers
3.2.2 Future developments in business structure by suppliers
3.2.3 Future developments in business structure by region
3.2.4 Future developments in business structure by company turnover
3.2.5 Future developments in business structure by senior level respondents
3.3 Change in Leading Company Strategies in the Global Pharmaceutical Industry
3.3.1 Change in leading company strategies by buyers
3.3.2 Change in leading company strategies by suppliers
3.3.3 Change in leading company strategies by region
3.3.4 Change in leading company strategies by company turnover
3.4 Merger and Acquisition (M&A) Activity Projections in the Global Pharmaceutical Industry
3.4.1 M&A activity projections by buyers
3.4.2 M&A activity projections by suppliers
3.4.3 M&A activity projections by region
3.4.4 M&A activity projections by company turnover
3.4.5 M&A activity projections by purchasing decision authority
3.4.6 Global pharmaceutical industry – expand abroad Vs M&A activity projections
3.5 Estimation of Capital Expenditure in the Global Pharmaceutical Industry
3.5.1 Estimation of capital expenditure by buyers
3.5.2 Estimation of capital expenditure by suppliers
3.5.3 Estimation of capital expenditure by region
3.5.4 Estimation of capital expenditure by company turnover
3.6 Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry
3.6.1 Planned change in staff recruitment activity by buyers
3.6.2 Planned change in staff recruitment activity by suppliers
3.6.3 Planned change in staff recruitment activity by region
3.6.4 Planned change in staff recruitment activity by company turnover
4 Global Pharmaceutical Industry Market Growth Outlook
4.1 Global Pharmaceutical Industry: Demand in Emerging Markets
4.1.1 Demand in emerging markets by buyers
4.1.2 Demand in emerging markets by suppliers
4.1.3 Demand in emerging markets by region
4.1.4 Demand in emerging markets by company turnover
4.2 Global Pharmaceutical Industry – Growth Projections in Developed Countries
4.2.1 Growth projections in developed countries by buyers
4.2.2 Growth projections in developed countries by suppliers
4.2.3 Growth projections in developed countries by region
4.2.4 Growth projections in developed countries by company turnover
5 Threats and Opportunities for the Global Pharmaceutical Industry
5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2013-2014
5.1.1 Leading business concerns for 2013-2014 by company type
5.1.2 Leading business concerns for 2013-2014 by region
5.1.3 Leading business concerns for 2013-2014 by company turnover
5.2 Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business
5.2.1 Actions to maintain and secure buyer business by buyers
5.2.2 Actions to maintain and secure buyer business by region
5.2.3 Actions to maintain and secure buyer business by company turnover
5.2.4 Actions to maintain and secure buyer business by purchasing decision authority
6 Global Pharmaceutical Industry – Supplier Marketing Spend Activity
6.1 Annual Marketing Budgets – Global Pharmaceutical Industry Suppliers
6.1.1 Annual marketing budgets by region – global pharmaceutical industry suppliers
6.1.2 Annual marketing budgets by company turnover – global pharmaceutical industry suppliers
6.2 Planned Change in Marketing Expenditure Levels – Global Pharmaceutical Industry Suppliers
6.2.1 Planned change in marketing expenditure by region – global pharmaceutical industry suppliers
6.2.2 Planned change in marketing expenditure by turnover – global pharmaceutical industry suppliers
6.2.3 Planned change in marketing expenditure by decision making authority – global pharmaceutical industry suppliers
6.2.4 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2013
6.3 Future Investment by Media Channel – Global Pharmaceutical Industry Suppliers
6.3.1 Future investment by media channel by region – global pharmaceutical industry suppliers
6.3.2 Future investment by media channel by company turnover – global pharmaceutical industry suppliers
6.4 Global Pharmaceutical Industry Suppliers’ Future Investment in Marketing and Sales
6.4.1 Planned investment in marketing and sales technologies by region – global pharmaceutical industry suppliers
6.4.2 Planned investment in marketing and sales by turnover: global pharmaceutical industry suppliers
7 Marketing and Sales Behaviors and Strategies in 2013-2014
7.1 Key Marketing Aims for 2013-2014 – Global Pharmaceutical Industry Suppliers
7.1.1 Key marketing aims by region – global pharmaceutical industry suppliers
7.1.2 Key marketing aims by company turnover – global pharmaceutical industry suppliers
7.2 Essential Amendments to Marketing Activities in 2013-2014
7.2.1 Amendments to marketing activities by company turnover – global pharmaceutical industry suppliers
7.3 Critical Success Factors for Choosing a Marketing Agency
7.3.1 Critical success factors for choosing a marketing agency by region
7.3.2 Critical success factors by company turnover – global pharmaceutical industry suppliers
8 Appendix
8.1 Global Pharmaceutical Industry Survey Results- Closed Questions
8.2 Methodology
8.3 Contact us
8.4 About ICD Research
8.5 Disclaimer